Drug Information Association Names New Worldwide Executive Director

Share Article

The Drug Information Association (DIA) is pleased to announce the appointment of Linda McGoldrick as its new Worldwide Executive Director. McGoldrick replaces William Brassington, who has served as Acting Executive Director since 2006.

One of my primary objectives is to establish a foothold in several emerging markets such as India, China, Eastern Europe, and Latin America that promise exciting opportunities from both business operations and educational perspectives.

The Drug Information Association (DIA) is pleased to announce the appointment of Linda McGoldrick as its new Worldwide Executive Director. McGoldrick replaces William Brassington, who has served as Acting Executive Director since 2006.

McGoldrick, the first woman to serve as DIA Worldwide Executive Director, brings to DIA more than 25 years’ experience in global business development, financial management, and product development in the financial services, healthcare, and life science industries. She says she is proud to have been chosen to lead an Association with such a proud and noble international tradition.

“I am excited to be part of the DIA cause of providing a universally respected neutral forum for information exchange on global drug development and discovery,” explains McGoldrick. “Serving as DIA Worldwide Executive Director offers a great opportunity to work every day with a diverse group of professionals, from many different disciplines, companies, governments, and countries. It is this type of global collaboration that allows DIA to remain at the forefront of innovation and to grow its portfolio of educational offerings.”

Prior to joining DIA, Linda was President and CEO of Financial Health Associations International (FHAI), where she led multinational teams in the creation and implementation of growth strategies for international companies; National Development Director and Senior Vice President at Marsh MMC Companies; and COO and Marketing Director at VEOS plc. Also, as Managing Director Europe for Kaiser Permanente International (KPI), she successfully launched KPI Europe and led the development, strategic growth, and management of KPI as the largest integrated healthcare provider globally. She has also served as Director of Business Development with Shearson American Express and as a management consultant with Arthur D. Little Inc.
“Linda comes to DIA with experience in both the healthcare and financial sectors on a global level,” says Ron Fitzmartin, President, DIA Board of Directors. “Drug research and development is truly global, and Linda’s successful track record of restructuring and transitioning organizations, promoting new business ventures, and creating strategic alliances are vital to DIA’s global mission and vision.”

In her role as Worldwide Executive Director, McGoldrick will manage the day-to day operations of the Association as well as provide direction on the implementation of the Association’s strategic plan.

“We want to continue to advance both our global presence as well as the value of DIA’s professional development and membership resources so that we can provide our members with the information they want and need.” says McGoldrick. “One of my primary objectives is to establish a foothold in several emerging markets such as India, China, Eastern Europe, and Latin America that promise exciting opportunities from both business operations and educational perspectives.”
McGoldrick holds an MSW in healthcare from the University of Pennsylvania and an MBA in finance from The Wharton School, University of Pennsylvania.

For more information or to schedule an interview, contact Joe Krasowski at 215-293-5812.

About the Drug Information Association (DIA)
The Drug Information Association serves more than 18,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, Pa., USA, and with offices in Basel, Switzerland and Tokyo, Japan, the Association is led by its volunteer-based board of directors and executive management team. For more information, visit http://www.diahome.org or call 215-442-6100.

Contact:
Joe Krasowski
215-293-5812

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Joe Krasowski
Visit website